What Researchers Did
Doctors at the University of Florida reviewed how they treated 12 patients who had Merkel cell carcinoma, a rare skin cancer, on the head and neck.
What They Found
In this case series of 12 patients with head and neck Merkel cell carcinoma treated with radiotherapy at one center, local-regional control was achieved in 7 of 8 patients treated at first diagnosis (group A) and in all 4 patients treated at local-regional recurrence (group B). One patient in group A and all patients in group B developed distant metastases and eventually died of their disease. Bone exposure developed in one patient, who needed surgical debridement and hyperbaric oxygen treatment. The authors suggest that local-regional recurrence is a harbinger of distant metastases, and they recommend treating both the primary site and draining lymphatics at first presentation.
What This Means for Canadian Patients
This report is mainly about radiotherapy for Merkel cell carcinoma, not about hyperbaric oxygen therapy. The abstract mentions hyperbaric oxygen only once, as part of the care for one patient who developed exposed bone, and it does not test or report how well it worked. The abstract also says the role of chemotherapy remains unclear.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small, single-center review of 12 patients with no comparison group, so it cannot show that one approach works better than another, and the abstract does not report any statistical testing.